Spain· ES:09545007
ONGLYZA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing saxagliptina, registered in Spain by Astrazeneca Ab.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- saxagliptina
- Manufacturer
- Astrazeneca Ab
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saxagliptina in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaONGLYZAAstraZeneca AB, Södertälje
- BelgiumOnglyza 5 mgAstraZeneca
- FranceONGLYZA 5 mg, comprimé pelliculéASTRAZENECA AB
- United StatesSaxagliptinAurobindo Pharma Limited
- NetherlandsOnglyza 5 mg, filmomhulde tablettenAstraZeneca AB
- IcelandOnglyzaAstraZeneca AB
- NorwayOnglyzaOrifarm AS
- PolandOnglyzaAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- France · Saxagliptine Arrow, Saxagliptine Biogaran
- United Kingdom (Northern Ireland) · Saxagliptin Sandoz, Saxagliptin Zydus Pharmaceuticals Uk
- Hungary · Saxagliptin Pharos
- Iceland · Onglyza
- Liechtenstein · Onglyza
- Malta · Saxagliptin Pharos
- Netherlands · Saxagliptine Sandoz
- Norway · Onglyza
- Portugal · Saxagliptina Generis, Saxagliptina Generis Phar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8d012615-348e-4e4b-9f81-ddd87c7150c0 GET /v1/drugs/8d012615-348e-4e4b-9f81-ddd87c7150c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1258066800000}",
"nregistro": "09545007",
"substance": "saxagliptina"
}See everything about saxagliptina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.